Published in J Biol Chem on September 18, 1998
Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J Bacteriol (2004) 1.57
Photonic activation of plasminogen induced by low dose UVB. PLoS One (2015) 1.41
Humanized in vivo model for streptococcal impetigo. Infect Immun (2000) 1.18
The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues. J Bacteriol (2006) 1.13
Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis. J Bacteriol (2007) 1.10
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infect Immun (2004) 1.09
Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo. Infect Immun (1999) 1.06
Plasminogen binding and activation by Mycoplasma fermentans. Infect Immun (2001) 1.04
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol (2012) 1.01
Bacterial plasminogen receptors: mediators of a multifaceted relationship. J Biomed Biotechnol (2012) 0.99
A natural inactivating mutation in the CovS component of the CovRS regulatory operon in a pattern D Streptococcal pyogenes strain influences virulence-associated genes. J Biol Chem (2013) 0.95
Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival. MBio (2013) 0.95
The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection. Am J Pathol (2003) 0.93
The generation and characterization of mice expressing a plasmin-inactivating active site mutation. J Thromb Haemost (2010) 0.92
Solution structure of the complex of VEK-30 and plasminogen kringle 2. J Struct Biol (2009) 0.82
Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein. J Biol Chem (2015) 0.82
Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria. J Biol Chem (2016) 0.79
Dimerization is not a determining factor for functional high affinity human plasminogen binding by the group A streptococcal virulence factor PAM and is mediated by specific residues within the PAM a1a2 domain. J Biol Chem (2014) 0.78
Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM). Biochim Biophys Acta (2010) 0.77
NMR backbone dynamics of VEK-30 bound to the human plasminogen kringle 2 domain. Biophys J (2010) 0.75
Variable region in streptococcal M-proteins provides stable binding with host fibrinogen for plasminogen-mediated bacterial invasion. J Biol Chem (2017) 0.75
Conformationally Organized Lysine Isosteres in Streptococcus Pyogenes M Protein Mediate Direct High-Affinity Binding to Human Plasminogen. J Biol Chem (2017) 0.75
Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum (1977) 3.51
Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet (1966) 3.27
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Evaluation of polymerase chain reaction, tuberculostearic acid analysis, and direct microscopy for the detection of Mycobacterium tuberculosis in sputum. J Infect Dis (1992) 2.24
Examination of the dissociation of multichain proteins in guanidine hydrochloride by membrane osmometry. Biochemistry (1968) 2.18
Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem (1999) 2.14
Hepatic involvement in juvenile rheumatoid arthritis. J Pediatr (1970) 2.05
The complete amino acid sequence of bovine alpha-lactalbumin. J Biol Chem (1970) 2.03
Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol (1996) 1.97
PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem (1993) 1.90
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Measurement of the binding of antifibrinolytic amino acids to various plasminogens. Arch Biochem Biophys (1972) 1.61
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest (1998) 1.55
Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature (1997) 1.50
Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis (1999) 1.48
Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. Am J Pathol (2001) 1.48
Neonatal imitation of tongue protrusion and mouth opening: methodological aspects and evidence of early individual differences. Scand J Psychol (1989) 1.48
In utero transplantation of wild-type fetal liver cells rescues factor X-deficient mice from fatal neonatal bleeding diatheses. J Thromb Haemost (2003) 1.47
Juvenile rheumatoid arthritis: a review. Pediatrics (1972) 1.46
Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res (2000) 1.46
Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol (2000) 1.45
Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J Immunol (1998) 1.44
Isolation and characterization of the structural gene for secreted acid phosphatase from Schizosaccharomyces pombe. J Biol Chem (1986) 1.43
Hypergammaglobulinaemia, antibody deficiency, autoimmune haemolytic anaemia, and nephritis in an infant with a familial lymphopenic immune defect. Lancet (1966) 1.38
Three-dimensional solution structure of an immunoglobulin light chain-binding domain of protein L. Comparison with the IgG-binding domains of protein G. Biochemistry (1994) 1.38
Human complement regulators: a major target for pathogenic microorganisms. Curr Opin Immunol (2000) 1.35
Proton nuclear magnetic resonance sequential assignments and secondary structure of an immunoglobulin light chain-binding domain of protein L. Biochemistry (1993) 1.35
Convergent evolution among immunoglobulin G-binding bacterial proteins. Proc Natl Acad Sci U S A (1992) 1.35
Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol (1998) 1.34
Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol (2001) 1.34
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci U S A (1997) 1.33
Activation of human plasminogen by equimolar levels of streptokinase. J Biol Chem (1977) 1.29
Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol (2001) 1.29
A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol (2000) 1.28
Identification of a plasminogen-binding motif in PAM, a bacterial surface protein. Mol Microbiol (1995) 1.27
Human plasminogen. Methods Enzymol (1981) 1.26
Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol (1998) 1.24
A characterization of native streptokinase and altered streptokinase isolated from a human plasminogen activator complex. Biochemistry (1974) 1.23
Mechanism of the urokinase-catalyzed activation of human plasminogen. J Biol Chem (1976) 1.23
Protein H--a surface protein of Streptococcus pyogenes with separate binding sites for IgG and albumin. Mol Microbiol (1994) 1.23
Oligosaccharide processing in the expression of human plasminogen cDNA by lepidopteran insect (Spodoptera frugiperda) cells. Biochemistry (1990) 1.22
A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Am J Pathol (2000) 1.22
A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost (2004) 1.22
The effect of alpha-,omega-amino acids on human plasminogen structure and activation. J Biol Chem (1978) 1.21
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost (2000) 1.20
Molecular co-operation between protein PAM and streptokinase for plasmin acquisition by Streptococcus pyogenes. J Biol Chem (1998) 1.17
Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol (2002) 1.17
Calcium binding properties of synthetic gamma-carboxyglutamic acid-containing marine cone snail "sleeper" peptides, conantokin-G and conantokin-T. Biochemistry (1996) 1.17
The denaturing effectiveness of guanidinium, carbamoylguanidinium, and guanylguanidinium salts. Biochemistry (1968) 1.16
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev (1998) 1.16
Streptokinase. Methods Enzymol (1976) 1.15
The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors. J Immunol (1989) 1.13
Interaction of streptokinase with plasminogen. Isolation and characterization of a streptokinase degradation product. J Biol Chem (1976) 1.12
Expression of human plasminogen in Drosophila Schneider S2 cells. Protein Expr Purif (1999) 1.12
Rabbit plasminogen and plasmin isozymes. Methods Enzymol (1976) 1.11
Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Biol Chem (1992) 1.11
Adenosine 5'-phosphosulfate sulfotransferase and adenosine 5'-phosphosulfate reductase are identical enzymes. J Biol Chem (2000) 1.11
Diagnosis of tuberculous meningitis: a comparative analysis of 3 immunoassays, an immune complex assay and the polymerase chain reaction. Tuber Lung Dis (1995) 1.11
Juvenile rheumatoid arthritis persisting inot adulthood. Am J Med (1968) 1.10
Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J Mol Biol (2001) 1.10
A coagulation factor VII deficiency protects against acute inflammatory responses in mice. J Pathol (2006) 1.09
Bacterial L-forms in relapsing urinary-tract infection. Lancet (1967) 1.08
Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease. Ann Intern Med (1972) 1.08
The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin. Arch Biochem Biophys (1975) 1.07
Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo. Infect Immun (1999) 1.06
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins. Eur J Biochem (1994) 1.05
The interaction of Ca2+ with human Factor IX. Arch Biochem Biophys (1981) 1.05
Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase. Biochemistry (1985) 1.05
Plant adenosine 5'-phosphosulfate reductase is a novel iron-sulfur protein. J Biol Chem (2001) 1.05
The binding-sites of rabbit muscle aldolase. Biochem Biophys Res Commun (1966) 1.04
The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors. J Biol Chem (1987) 1.03
The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase. Proc Natl Acad Sci U S A (1987) 1.03
Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface. J Biol Chem (2001) 1.03
The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. J Biol Chem (2001) 1.01
Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG. Mol Immunol (1988) 1.01
Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun (2010) 1.01
Domain interactions between streptokinase and human plasminogen. Biochemistry (2001) 1.01
Purification and characterization of crotonase from Clostridium acetobutylicum. J Biol Chem (1972) 1.01
Multiplicity of rabbit plasminogen. Physical characterization. Biochemistry (1972) 1.00
Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1. Am J Pathol (2001) 1.00
Expression of three recombinant proteins using baculovirus vectors in 23 insect cell lines. Biotechnol Prog (1991) 0.99
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry (1999) 0.99
Staphylococcus aureus induces release of bradykinin in human plasma. Infect Immun (2001) 0.99
Mapping of the immunoglobulin light chain-binding site of protein L. J Mol Biol (1995) 0.99
Ankylosing spondylitis with childhood onset. J Pediatr (1969) 0.98
Arthritis as a presenting manifestation of malignancy in children. J Pediatr (1972) 0.98
Nonfibrinolytic functions of plasminogen. Methods (2000) 0.98
Conformational properties of streptokinase. J Biol Chem (1989) 0.97
Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin). Proc Natl Acad Sci U S A (1992) 0.97
Structural studies on bovine lactoferrin. J Biol Chem (1970) 0.97
Arthritis and immunodeficiency. J Pediatr (1972) 0.96